| Rituxan |
an immunotherapy drug used to treat a variety of non-Hodgkin's lymphomas. Clinical studies are underway to determine the efficacy of Rituxan in treating chronic lymphomcytic leukemia (CLL), Waldenstrom's macroglobulinemia, and other cancers of the blood.
출처: www.leukemialymphomafyi.com/cancer_glossary.html
|
|---|---|
| Rituxan |
The first monoclonal antibody found to be effective and safe for the treatment of cancer in the US. Rituxan?is indicated for the treatment of patients with relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL. Rituxan?is a US registered trademark of Biogen Idec Inc.
출처: www.inexpharm.com/FAQ/Glossary.asp
|